HLA Typing For Transplant Market To Reach USD 46.8 Billion By 2025 – Increasing Demand For Organ Donation

 What This Report Will Provide?

The study involved four major activities in estimating the current size of the HLA typing for the transplants market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. 

Expected Revenue Growth :

[193 Pages Report] The HLA typing for the transplants market is expected to reach USD 968 million by 2025 from USD 656 million in 2019, at a CAGR of 6.7%.

Major Growth Boosters :

The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing burden of infectious diseases, the growing number of transplant procedures, and technological advancements in the field of transplant diagnostics.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=96374742 

Key Questions Addressed by the Report:

• What are the growth opportunities related to the adoption of HLA typing for transplant products across significant regions in the future?
• Emerging countries show immense opportunities for the growth and adoption of HLA typing for transplant instruments, related reagents & consumables, and software. Will this scenario continue in the next five years?
• Where will the advancements in products offered by various companies take the industry in the mid- to long-term?
• What are the newest trends and advancements in the HLA typing for the transplants market?

The independence reference laboratories end-user segment accounted for the largest share of the HLA typing for transplants market in 2019

Based on end-user, the HLA typing for the transplants market is segmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. In 2019, independent reference laboratories accounted for the largest share of the HLA typing for the transplants market. The large share of this segment can be attributed to the rapid modernization and automation of diagnostic laboratories, growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories, and the growing number of organ transplantation procedures.

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=96374742

By product & service, the product segment is expected to be the largest contributor to the intraoperative radiation therapy market

On the basis of product & service, the intraoperative radiation therapy market is segmented into IORT products and services. In 2019, the products segment is expected to account for the largest market share. The larger share of this segment can be attributed to their growing availability; development of technologically advanced mobile systems/accelerators, treatment planning, and growing applications of IORT products in cancer treatment.

Regional Growth Analysis:

North America is a well-established market for medical devices. The presence of a highly developed healthcare system, high adoption of innovative transplant diagnostic technologies (includes HLA typing) among medical professionals, the large volume of organ transplantation procedures performed in the region, and technological advancements in the field of transplant diagnostics are the major factors driving the market in North America.

Solvent Evaporation Market To Reach USD 694 million by 2024 - Growing Demand For Pharmaceutical and Biopharmaceutical

 Growth in this market is driven majorly by the growth of the biologics sector, increasing research & development expenditure, rising purity demands in end-use markets, and the growing development of large molecule biopharmaceuticals.

What the Market Looks Like?

The global solvent evaporation market size is projected to reach USD 694 million by 2024 from USD 487 million in 2019, at a CAGR of 7.3%. North America is expected to account for the largest share of the solvent evaporation market in 2018.

Rotary evaporators are expected to be the most significant revenue contributor to the global market in 2018. The large share of this segment can be attributed to the increasing demand for efficient & pure samples, growing investments in research & development by research institutes, rising demand for industrial-scale automation in terms of digitization, and the growing need for advanced analytical tools during drug diagnosis & research studies.

Download PDF Brochure @  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=68290365

What are Key Trends in the Market?

The growth of the Solvent Evaporation Market is primarily influenced by the following factors:

• Increasing R&D Expenditure
• Increasing Demand for Pure Samples in End-Use Markets
• Growing Development of Large-Molecule Biopharmaceuticals

The solvent evaporation market, by the end-user, includes pharmaceutical & biopharmaceutical industry, diagnostic laboratories, and research & academic institutes. The research & academic institutes segment is expected to grow at the highest CAGR during the forecast period due to factors such as the increasing drug development studies and the rising demand for continuous innovation and enhancement of existing products.

The rotary evaporators segment is expected to account for the largest solvent evaporators market share in 2018

Rotary evaporators are expected to be the most significant revenue contributor to the global market in 2018. The large share of this segment can be attributed to the increasing demand for efficient & pure samples, growing investments in research & development by research institutes, rising demand for industrial-scale automation in terms of digitization, and the growing need for advanced analytical tools during drug diagnosis & research studies.

Read more about solvent evaporation market@ https://www.marketsandmarkets.com/requestsampleNew.asp?id=68290365

China cardiology information system market To Reach USD 54 million - Current And Future Perspectives 2024

 What This Report Will Provide?

The study involved four major activities in estimating the current market size of the China cardiology information system market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. 

Expected Revenue Growth :[54 Pages Report] The China cardiology information system market is projected to reach $54 million by 2024 from $35 million in 2019, at a CAGR of 8.9% during the forecast period.

Major Growth Boosters :

Growth in this market is mainly driven by the increasing incidence and prevalence of cardiovascular disease, government initiatives in China, and the increasing number of hospitals.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=264168583

L3A hospitals accounted for the largest share of the China cardiology information system market in 2018

Based on end user, the market is segmented into L3A hospitals and L3B & L2 Hospitals. The L3A hospitals segment accounted for the largest share of the market in 2018. The increasing number of L3A hospitals in China and growing disease prevalence are responsible for the large share of this market segment.

Key Questions Addressed in The Report:

• What are the growth opportunities offered by the market in the next five years?
• How will advancements in products offered by various companies affect the market scenario in the mid- to long-term?
• What are the trends and advancements in the China cardiology information system market?

Request Sample Report :  https://www.marketsandmarkets.com/requestsampleNew.asp?id=264168583

The integrated systems segment is expected to grow at the highest CAGR during the forecast period

Based on system, the market is segmented into integrated and standalone systems. The integrated systems segment is projected to witness the highest growth during the forecast period. The increasing adoption of integrated systems by healthcare providers is the major factor supporting the growth of this segment.

Regional Growth Analysis:

Geographically, the biomaterials market is segmented into North America, Europe, Asia Pacific, and Rest of the World. In 2019, North America accounted for the largest share of the biomaterials market, followed by Europe and the Asia Pacific. The large share of North America in the global market is attributed to the increase in biomaterial-based research, rising demand for plastic surgeries, growing incidence of cancer, and the rising prevalence of cardiovascular diseases.

Filter Integrity Test Market Worth USD 79 million by 2024 (At a CAGR of 5.0%)

 What This Report Will Provide?

The study involved 4 major activities in estimating the current market size for filter integrity test. Exhaustive secondary research was done to collect information on the market as well as its peer and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research.

Expected Revenue Growth :

[106 Pages Report] The filter integrity test market is projected to reach USD 79 million by 2024 from USD 59 million in 2018, at a CAGR of 5.0% during the forecast period. 

Major Growth Boosters:

Factors such as increasing R&D spending, growth in the biopharmaceutical industry, and increasing purity requirements in the end-user market are driving the growth of the market.

Download PDF Brochure : https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=4687390

Recent Developments :

• In 2018, Thermo Fisher Scientific opened the new Bioprocess Design Center in Shanghai, China to connect and collaborate with biologic developers to design bioprocessing solutions.
• Merck opened a new manufacturing and distribution center for its life science business in Mumbai, India to increase its gross domestic product storage and meet future bioproduction demand.
• Thermo Fisher Scientific acquired the Advanced Bioprocessing business from Becton, Dickinson and Company. With this acquisition, the company expanded its product portfolio of life sciences solutions.

Key Questions Addressed in The Report:

• Who are the major players in the market?
• What are the regional growth trends and the largest revenue-generating region for the filter integrity test market?
• What are the major drivers and opportunities of the filter integrity test market?
• Which is the major test type of filter integrity test?
• Who are the major end users of the filter integrity test market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=46873904 

Based on type, the market is segmented into diffusion test, water flow integrity test, and bubble point test. In 2018, the diffusion test segment accounted for the largest share of the filter integrity test market. This segment is also expected to witness the highest growth during the forecast period. The advantages offered by the diffusion testing method such as high sensitivity, high margin of safety, and testing of the complete filter system (cartridge and housing) are supporting the growth of this segment.

Regional Growth Analysis:

The market is divided into four major regions—North America, Europe, Asia Pacific, and the Rest of the World (RoW). In 2018, North America accounted for the largest share of the market, followed by Europe. The increasing demand for biopharmaceuticals and implementation of drug safety guidelines by the FDA are the major factors driving the growth of the filter integrity test industry in North America.

Genotyping Assay Market To Reach USD 31.9 billion by 2023 – Increasing Investment In Pharmacogenomics

 What This Report Will Provide?

Technical advancements have allowed for miniaturization, automation, and reduced overall costs, as well as operational flexibility and the incorporation of multi-parameter testing. All of these have greatly helped increase the applications and convenience of DNA sequencing, allowing physicians to focus on high-level decision-making such as identifying and prioritizing drug targets through various genotyping studies.

Expected Revenue Growth :

MarketsandMarkets forecasts the Genotyping Assay market to grow from USD 11.8 billion in 2018 to USD 31.9 billion by 2023, at a Compound Annual Growth Rate (OTC:CAGR) of 22.0% during the forecast period.

Major Growth Boosters :

The major factors that are expected to be driving the genotyping assay market are technological advancements and the decreasing prices of DNA sequencing. The increasing incidence of genetic diseases and rising awareness of personalized medicine, growing importance of genotyping in drug development, and the increasing demand for bioinformatics solutions in data analysis are also expected to promote market growth in the coming years.

Download PDF Brochure:   https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=249958595 

Recent Developments :

• In May 2018, Agilent technologies opened a new logistics center in Texas to increase its capacity for house inventory and to fulfill the growing demand for NGS products from its genomics group.
• In March 2018, Danaher Corporation acquired Integrated DNA Technologies Inc. (US). This acquisition strengthened Danaher’s Life Sciences platform. IDT will operate as a standalone operating company and brand within Danaher Corporation.
• In January 2018, Thermo Fisher Scientific signed a partnership with Illumina (US) that enabled Illumina to sell the Ion AmpliSeq technology to researchers who conduct scientific studies using Illumina’s next-generation sequencing (NGS) platforms.
• In January 2018, Illumina launched the iSeq 100 Sequencing System.
• In January 2018, Thermo Fisher Scientific launched the Ion GeneStudio S5 Series Instrument.

Frequently Asked Questions (FAQ):

• Where will all these developments take the industry in the long term?
• What are the upcoming trends for the genotyping market?
• Which segment provides the most opportunity for growth?
• Who are the leading players operating in this market?
• What are the opportunities for new market entrants?

Request Sample Report:   https://www.marketsandmarkets.com/requestsampleNew.asp?id=249958595 

By technology, the sequencing segment to record the highest CAGR during the forecast period

The sequencing segment is expected to witness a faster growth rate in this market due to factors such as, the increasing application areas of DNA sequencing technologies, technological advancements, the availability of high-speed sequencing instruments, and the growing uptake of the hybrid approach of sequencing.

Regional Growth Analysis:

North America is expected to hold the largest market size in the global genotyping market during the forecast period, followed by the European region. The increasing adoption of technologically advanced genotyping products, the high healthcare expenditure, presence of advanced healthcare infrastructure, highly developed healthcare systems in the US and Canada, large number of genotyping-based R&D projects, and the presence of a large number of leading genotyping manufacturers in the region, along with an increasing demand from pharmaceutical companies for genotyping products and rising investments by government bodies, are responsible for the large share of the North American genotyping market.

Patient Access Solutions Market To Reach USD 2.4 billion by 2025 – Expansion in Emerging Economies

 What This Report Will Provide?

This study involved four major activities for estimating the current size of the Patient access solutions market. Exhaustive secondary research was conducted to collect information on the market and its peer and parent markets.

The next step focused on validating these findings, assumptions, and sizing with industry experts across the value chain through primary research. Revenue Share Analysis, Parent Market, and top-down approaches were employed to estimate the complete market size.

Expected Revenue Growth:

[207 Pages Report] The global patient access solutions market is projected to reach USD 2.4 billion by 2025 from USD 1.6 billion in 2020, at a CAGR of 8.5%.

Major Growth Boosters:

Increasing patient volume and subsequent growth in the demand for health insurance, the growing importance of denials management, declining reimbursement rates, increase in the volume of unstructured data in the healthcare industry, and the rising need to curtail escalating healthcare costs are the major factors driving the growth of this market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=280473

Recent Developments

• In October 2019, Cerner signed an agreement to acquire AbleVets.
• In July 2019 RxCrossroads by McKesson launched AMP: Access for More Patients, a patient support solution.
• In July 2019, Cognizant and Medidata signed an agreement to develop new solutions for pharmaceuticals
• In April 2019, Experian Health and Change Healthcare partnered.
• In 2017, Optum acquired the healthcare division of The Advisory Board.

Key Questions Addressed in The Report:

• Which type of product is leading the by product & service type segment?
• Which type of delivery mode is leading the market?
• Which is the leading end-user segment of Patient access solutions market?
• Who are the key players operating in the Patient access solutions market?
• Which country is dominating in the Patient access solutions market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=280473

Lucrative growth opportunities in emerging markets

The Asia Pacific region is a highly lucrative market for patient access solutions owing to the implementation of various government initiatives focused on the greater adoption of healthcare IT solutions in China, India, and Australia and the rising government spending on healthcare.

Regional Growth Analysis:

The Asia Pacific market is comparatively new to patient access solutions; however, this region is expected to register the highest growth in the coming years. Countries such as Japan, Australia, New Zealand, South Korea, and Singapore are expected to provide significant growth opportunities for vendors of patient access solutions.

Particle Therapy Market : Technological Advancements In The Field Of Proton Therapy

 What This Report Will Provide?

The study involved four major activities to estimate the current market size for particle therapy. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Expected Revenue Growth :

The global particle therapy market is projected to reach USD 1,349 million by 2023 from USD 865 million in 2018, at a CAGR of 9.3%.

Major Growth Boosters :

Growth in the particle therapy market is primarily driven by factors such as the various advantages offered by particle therapy over photon therapy, growing global prevalence of cancer, increasing adoption of particle therapy in clinical trials, and the increasing number of particle therapy centers worldwide.

Download PDF Brochure:  https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=12809137

Recent Developments : 

• In May 2020, BioIVT (US) introduced high-purity Kupffer cells to its portfolio of human primary hepatic cells to support liver disease drug discovery and development.
• In January 2020, Charles River Laboratories acquired HemaCare Corporation. This acquisition will aid in expanding Charles River’s scientific capabilities in the high-growth cell therapy sector.
• In September 2018, Sekisui XenoTech, LLC. (US) added monkey and rodent hepatocytes to its patented CryostaX product line.

Key questions addressed by the report :

• What are the growth opportunities related to the adoption of heavy ion therapy across major regions in the future?
• Emerging countries have immense opportunities for the growth and adoption of particle therapy. Will this scenario continue in the next five years?
• Where will all the advancements in products offered by various companies take the industry in the mid- to long-term?
• What are the various cancer types wherein particle therapy finds a high adoption rate?
• What are the new trends and advancements in the particle therapy market?

Request Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=12809137

By product, the synchrotron segment is expected to grow at the highest rate during the forecast period

Synchrotrons are used to accelerate both protons and heavy ions such as carbon and hydrogen. The growth of the synchrotrons segment is attributed to factors such as the increasing number of research activities as well as the increasing investments in the development of synchrotron facilities.

Regional Growth Analysis:

The Asia Pacific is one of the major revenue generating regions in the particle therapy market. China and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, growing incidence of cancer, and rising acceptance of particle therapy procedures and devices are also driving the growth of this regional market.

Hemato Oncology Testing Is At Forefront Of Oncology Nutrition Market- Industry Analysis Report 2023

 What This Report Will Provide?

Factors such as shifting focus from parenteral to enteral nutrition, increasing incidence of cancer, growing demand for nutritional feeding in the homecare sector, rising number of patients being treated for malnutrition, and increasing quality of clinical research on nutritional interventions are driving the market growth.

Expected Revenue Growth:

[92 Pages Report] The oncology nutrition market was valued at USD 1.34 Billion in 2017 and is expected to reach USD 2.21 Billion by 2023, at a CAGR of 8.7% during the forecast period. 

Major Growth Boosters:

Factors such as the development of elemental formulas and product innovation in terms of non-GMO-based formulas present significant opportunities for the growth of oncology-based nutrition formulas.

The reducing cost of sequencing and growing volume of data generated during sequencing, growing focus on outsourcing for the management of large volumes of data, and the emerging markets are also expected to present growth opportunities for players in the market.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166703967

Objectives of the Study

• To define, describe, segment, and forecast the oncology nutrition market for different types of cancer
• To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, and industry-specific opportunities)
• To forecast the size of the oncology nutrition market, in four main regions —North America (along with countries), Europe (along with countries), Asia Pacific, and the Rest of the World
• To identify and profile key players in the global oncology nutrition market and comprehensively analyze their core competencies and market shares
• To track and analyze competitive developments such as mergers and acquisitions; new product launches; expansions; collaborations and agreements; and R&D activities of the leading players in the global oncology nutrition market

Request Sample Report:  https://www.marketsandmarkets.com/requestsampleNew.asp?id=166703967

The report analyzes the oncology nutrition market by type of cancer and region. Based on cancer type, the head and neck cancers segment accounted for the largest share of the market in 2017. Patients with head and neck cancers suffer from severe problems associated with oral nutritional intake. Thus, the enteral route is used for nutrition support. With the increasing number of such cancers cases, the uptake of tube feeding formulas has increased. 

Regional Growth Analysis: 

Geographically, the oncology nutrition market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2017, North America accounted for the largest share of this market. However, the Asia Pacific region is expected to witness the highest CAGR during the forecast period of 2018 to 2023. The growth of this segment can be attributed to the increased awareness and accessibility to advanced healthcare facilities, rising healthcare spending, large population base, and rapid improvements in the health insurance sector.

Key Market Players

The major players in the oncology nutrition market are Abbott Laboratories (US), Nestle S.A. (Switzerland), Danone (France), Fresenius Kabi AG (Germany), and B.Braun Melsungen AG (Germany). The other players in this market include Mead Johnson Nutrition Company (US), Hormel Foods (US), Meiji Holdings (Japan), Victus (US), and Global Health Products (US).